Origins of cardiac dysfunction in cirrhosis

Jim''nez W; Arroyo V
October 2003
Gut;Oct2003, Vol. 52 Issue 10, p1392
Academic Journal
No abstract available.


Related Articles

  • NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis. Licata, Anna; Corrao, Salvatore; Petta, Salvatore; Genco, Chiara; Cardillo, Mauro; Calvaruso, Vincenza; Cabibbo, Giuseppe; Massenti, Fatima; Cammà, Calogero; Licata, Giuseppe; Craxì, Antonio // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Background and Aims: Plasma levels of NT-pro-BNP, a natriuretic peptide precursor, are raised in the presence of fluid retention of cardiac origin and can be used as markers of cardiac dysfunction. Recent studies showed high levels of NT pro BNP in patients with cirrhosis. We assessed NT pro-BNP...

  • Cardiac Cirrhosis-An Uncommon Manifestation of Common Disease. Khare, Jaideep; Srivastava, Prachi; Wadhwa, Jyoti; Deb, Prasun // Oncology, Gastroenterology & Hepatology Reports;Jan-Jun2017, Vol. 6 Issue 1, p28 

    Background: Chronic Right Heart failure is known to cause Liver Cirrhosis but it is rare. Here we are reporting the case of cardiac cirrhosis presented to us with signs of Liver Failure. Case Report : 50 year male, farmer, chronic smoker presented with progressive abdominal distension and...

  • Cirrhotic Multiorgan Syndrome. Møller, Søren; Bendtsen, Flemming; Møller, Søren // Digestive Diseases & Sciences;Nov2015, Vol. 60 Issue 11, p3209 

    Patients with cirrhosis and portal hypertension are at an increased risk of the development of circulatory dysfunction that may potentially result in multiple organ failure. Apart from the liver, this may involve the heart, lungs, kidneys, the immune system, the adrenal glands, and other organ...

  • Relationship between NT-proBNP and Cardio-Renal Dysfunction in Patients with Advanced Liver Cirrhosis. Cavasi, Adriana; Cavasi, Eduard; Grigorescu, Mircea; Sitar-Taut, Adela // Journal of Gastrointestinal & Liver Diseases;Mar2014, Vol. 23 Issue 1, p51 

    Background & Aims: ProBNP is a sensitive marker of cardiac dysfunction. We assessed the concentration of circulating NT-proBNP in patients with liver cirrhosis in various stages of the disease and its correlation with markers of cardiac and renal dysfunction and with markers of liver disease...

  • Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Florence Wong // Gut;May2011, Vol. 60 Issue 5, p702 

    OBJECTIVES: To propose an improvement on the current classification of renal dysfunction in cirrhosis. Clinicians caring for patients with cirrhosis recognize that the development of renal dysfunction is associated with significant morbidity and mortality. While most cases of renal dysfunction...

  • Cardiac Function in Patients with Early Cirrhosis during Maximal Beta-Adrenergic Drive: A Dobutamine Stress Study. Krag, Aleksander; Bendtsen, Flemming; Dahl, Emilie Kristine; Kjær, Andreas; Petersen, Claus Leth; Møller, Søren // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Background and aim: Cardiac dysfunction in patients with early cirrhosis is debated. We investigated potential cardiac dysfunction by assessing left ventricular systolic performance during a dobutamine stress test in patients with early cirrhosis. Patients and methods: Nineteen patients with...

  • Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis.  // Current Medical Literature: Gastroenterology;2011, Vol. 30 Issue 3, p93 

    A review of the article "Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis," by F. Wong and colleagues is presented, which looks into alternative methods of classifying renal dysfunction in cirrhosis.

  • To block, or not to block in advanced cirrhosis and ascites: that is the question. Krag, Aleksander; Madsen, Bjørn Staehr // Gut;Jul2015, Vol. 64 Issue 7, p1015 

    The authors focus on a study conducted by researcher J.A. Leithead related to the usage of non-selective beta blockers (NSBB) in the treatment of cirrhosis and ascites. It mentions the higher rate of survival without a liver transplant in patients who received NSBB treatment. It states the...

  • Cardiovascular Changes in Cirrhosis: Pathogenesis and Clinical Implications. Al-hamoudi, Waleed K. // Saudi Journal of Gastroenterology;Jul2010, Vol. 16 Issue 3, p145 

    Liver cirrhosis is associated with a wide range of cardiovascular abnormalities including hyperdynamic circulation, cirrhotic cardiomyopathy, and pulmonary vascular abnormalities. The pathogenic mechanisms of these cardiovascular changes are multifactorial and include neurohumoral and vascular...

  • LIVER CIRRHOSIS AND CONGESTIVE HEART FAILURE AT PGI CIKINI HOSPITAL. Andira, Ayu; Ramatillah, Diana Laila; Lukas, Stefanus // Wood Industry / Drvna Industrija;2015 Supplement1, Vol. 6 Issue 1, p1945 

    Liver cirrhosis is a disease in which the micro-circulation, a large blood vessel anatomy and the entire system architecture of the liver becomes irregular changes and the addition of connective tissue (fibrosis) around the regenerated liver parenchyma. Factor precursor liver cirrhosis:...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics